Dialysis Centers

A dialysis center is a type of facility which offers life support service for patients suffering from lost kidney function. These centers can provide treatments to patients at a free-standing facility or at the patient’s home. Additionally, they may be operated as a hospital department.

Dialysis Clinics are typically valued for the sale to or from a national / regional operator, or a hospital operator. Additionally, a center can be valued for individual physician investment.

Value Drivers

The appraiser must understand many industry specific factors when valuing a Dialysis Center. Key value drivers include, but are not limited to:

  • Reimbursement: Typically, Medicare is the primary payor for the majority of a Dialysis Clinic’s patients, with a small percentage of patient’s insured by a commercial payor. Understanding the historical and reimbursement for each of these two groups is critical in the valuation process.
  • Equipment Capacity and Capital Expenditures: The potential patient treatment volumes a center can accommodate is related to the number of dialysis machines available at the Dialysis Clinic. This relationship as well as the capital investments required to add or replace machines is important in a Dialysis Center valuation.
  • Medication Costs: Medication costs are frequently the largest cost group for a center as each patient is required to receive a certain level of Medication for each treatment. Medication expenses will fluctuate directly with changes in patient treatment volumes, and therefore, the drivers of historical and projected Medication costs should be understood in the valuation.

There are many unique items to consider in the valuation of a Dialysis Clinic that necessitate a depth of knowledge and experience. VMG Health’s detailed experience with Dialysis Center valuations gives you the confidence you need to complete your transaction.

Relevant Publications on Dialysis Centers

Will Current Dialysis Treatment Trends Accelerate Under COVID-19
Vascular Access Center Valuation Considerations in 2017